Jasper W.L. Hartog
- Clinical Biochemistry top 0.2%
- Cardiology and Cardiovascular Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Nephrology top 2%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Andries J. SmitAdriaan A. VoorsDirk J. van VeldhuisenRijk O. B. GansRobbert MeerwaldtStephan J. L. BakkerReindert GraaffThera P. Links
- Topics
- Advanced Glycation End Products research (16 papers)Chronic Kidney Disease and Diabetes (9 papers)Cardiovascular Function and Risk Factors (7 papers)
- Journals
- CirculationAnnals of the New York Academy of SciencesJournal of the American Society of Nephrology
- Partner nations
- NetherlandsItalyPakistan
In The Last Decade
Jasper W.L. Hartog
19 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Clinical Biochemistry 911
- Cardiology and Cardiovascular Medicine 442
- Endocrinology, Diabetes and Metabolism 403
- Nephrology 239
- Pathology and Forensic Medicine 189
Countries citing papers authored by Jasper W.L. Hartog
This map shows the geographic impact of Jasper W.L. Hartog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasper W.L. Hartog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasper W.L. Hartog more than expected).
Fields of papers citing papers by Jasper W.L. Hartog
This network shows the impact of papers produced by Jasper W.L. Hartog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasper W.L. Hartog. The network helps show where Jasper W.L. Hartog may publish in the future.
Co-authorship network of co-authors of Jasper W.L. Hartog
This figure shows the co-authorship network connecting the top 25 collaborators of Jasper W.L. Hartog. A scholar is included among the top collaborators of Jasper W.L. Hartog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasper W.L. Hartog. Jasper W.L. Hartog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 52 | |
| 3 | 99 | |
| 4 | 39 | |
| 5 | 22 | |
| 6 | 44 | |
| 7 | 59 | |
| 8 | 2 | |
| 9 | 20 | |
| 10 | 42 | |
| 11 | 39 | |
| 12 | Abstract 2389: Clinical and Prognostic Value of Advanced Glycation End-products (AGEs) in Chronic Heart Failure | 2 |
| 13 | 211 | |
| 14 | 80 | |
| 15 | Vergrijzing is een verborgen zegen | 0 |
| 16 | 43 | |
| 17 | 305 | |
| 18 | 169 | |
| 19 | 77 | |
| 20 | 31 |
About Jasper W.L. Hartog
Jasper W.L. Hartog is a scholar working on Clinical Biochemistry, Nephrology and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (16 papers), Chronic Kidney Disease and Diabetes (9 papers) and Cardiovascular Function and Risk Factors (7 papers). The work is most often cited by research in Clinical Biochemistry (911 citations), Nephrology (239 citations) and Endocrinology, Diabetes and Metabolism (403 citations). Jasper W.L. Hartog has collaborated with scholars based in Netherlands, Italy and Pakistan. Frequent co-authors include Andries J. Smit, Adriaan A. Voors, Dirk J. van Veldhuisen, Rijk O. B. Gans, Robbert Meerwaldt, Stephan J. L. Bakker, Reindert Graaff, Thera P. Links, John Baynes and Suzan Willemsen. Their work appears in journals such as Circulation, Annals of the New York Academy of Sciences and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.